Archive for the ‘Activism’ Category

Tell EPA to Ban Glyphosate Now

https://organicconsumers.org/organic-bytes-newsletter-924-the-glyphosate-crisis-why-immediate-action-is-needed/

TAKE ACTION

Tell the EPA to Ban Glyphosate Now

The Environmental Protection Agency (EPA) is facing an October 1, 2026, deadline to reassess the safety of glyphosate, a widely used weedkiller linked to serious health concerns.

With a major scientific 25-year-old landmark study relied upon to prove the safety of glyphosate recently retracted, it’s clear that the EPA must take immediate action to move up the reassessment date!

The facts should be alarming to us all: the key paper relied on by the EPA for glyphosate safety assessments was retracted due to serious ethical concerns and questions about the validity of the research findings. The study’s conclusions were based on unpublished data from Monsanto, and the authors did not disclose financial compensation they received from Monsanto for their work.

Bayer has paid out over $10 billion in 100,000 Roundup cancer cases, and faces massive liability from thousands of additional lawsuits alleging its Roundup herbicide (with glyphosate being the active ingredient) causes cancer, so it is no surprise that Bayer is seeking to avoid liability in ongoing lawsuits related to glyphosate exposure by including pursuing appeals, lobbying for legislation, and seeking U.S. Supreme Court intervention.

Due to mounting scientific evidence linking glyphosate to cancer and other severe health issues in humans and animals, and concerns about its impact on pollinators and ecosystems, we need to act now!

TAKE ACTION NOW: Tell the EPA to prioritize public health and safety over industry interests by reopening the decision on glyphosate’s safety immediately and ban glyphosate to end the ongoing chemical assault on our land, water, and health!

When the Vaccine Schedule Changes, Vaccinators Panic: Watch Who Screams Loudest

When the Vaccine Schedule Changes, the Vaccinators Panic

By Susan Sweetin

NVIC’s Chief Marketing Officer

This week, officials at the Centers for Disease Control and Prevention quietly did something extraordinary, something the co-founders and followers of NVIC have been championing for over four decades.

They thoughtfully changed the childhood vaccine schedule.

The schedule was changed to align more with streamlined vaccine schedules of other developed nations like Denmark. The changes were fundamental enough to trigger a near-instant legacy media pile-on characterized by political outrage and what can only be described as pharmaceutical industry-driven panic.

Within hours, headlines rolled out notifying the public of the change: 

  • “What to Know About the New Childhood Vaccine Schedule”
  • “Health officials slash the number of vaccines recommended for all kids”
  • “CDC changes childhood immunization schedule, removing universal recommendation for multiple shots”
  • “CDC Slashes Universal Vaccine Recommendations”

And then came the tone shift – from reporting to orchestrated narrative.

It didn’t take long for PR agencies and media outlets representing old guard mandatory vaccinators to go on the attack. Opinion writers scolded the public for doubting the safety and urgent need to give children more than 72 doses of 17 vaccines.  Senators questioned the legitimacy of HHS policymakers reducing the number of recommended vaccine doses by more than 50 percent . Cable news framed the schedule change as dangerously confusing for parents and doctors. 

The message from the vaccinators is clear: nothing needs to change and you don’t need to think, you just need to trust us and do what we tell you to do.  

That reaction tells you everything.

The Science Didn’t Collapse, It Changed Who Decides.

As Barbara Loe Fisher explained in her June 2023 commentary “It Is Time to Declare Our Independence from the Vaccinators,”  (watch it here), from the very first vaccine for smallpox, the mass vaccination system has suffered from a structural conflict of interest through a tangled web of lucrative public-private business partnerships powered by chemical companies and governments. The same individuals who develop, sell, regulate, promote, monitor, administer and mandate vaccines also have dominated the U.S. vaccine advisory committees making national vaccine policy recommendations. 

That model depends on uniform compliance. The moment vaccine recommendations shift away from the “one-size-fits-all” and “no exceptions” approach, the illusion of inevitability cracks with it and there is room for the informed consent principle, not authority and coercion, to prevail.

Universal Vaccine Mandates Are About Control, Not Health

Universal vaccine use recommendations are administratively convenient. They are politically powerful. They are profitable. They are not synonymous with personalized medicine.

When CDC officials adjust the vaccine schedule – even modestly – it implicitly acknowledges what parents have been saying for years: children are not biologically all alike, not interchangeable units, and the risks of vaccines are not evenly distributed.

That acknowledgment inherent in the recent childhood vaccine schedule change is what rattles the system. Because once medical decisions are personalized out of respect for the life of each individual, coercion becomes indefensible and informed consent must be allowed. 

Watch Who Screams the Loudest Right Now

Notice who is most alarmed by the schedule change:

  • media outlets that dismissed parental concerns for decades
  • political figures who default to “trust the experts” rhetoric
  • commentators framing truth and transparency as chaos

And notice what’s missing:

  • calm explanations of why the vaccine schedule change was made
  • acknowledgment that science evolves and nothing stays the same 
  • respect for freedom of thought and conscience as parents navigate medical decisions for their children 

Instead, the public is being warnednot informed.

Independence Was Always the Threat

NVIC has consistently stated that true vaccine policy reform begins with restoring the foundational principle of informed consent to medical risk taking – the ethical standard articulated in the Nuremberg Code that applies to all medical interventions in experimental and clinical settings alike. See NVIC’s Guide to Reforming Vaccine Policy and Law here.

The orchestrated negative reaction to this childhood vaccine schedule change confirms that the real concern of mandatory vaccinators is not measles, pertussis, COVID, or other infectious diseases, it’s public awareness that the final decision about vaccination belongs to the individual, including parents of minor children, and not to a doctor or public health official.

A Final Thought

If vaccine schedules are as scientifically unassailable as we’re told, then transparency should strengthen public trust, not threaten it.

And if the medical and public health institutions respond to every vaccine policy change with outrage, blame, and media hype promoting false narratives, then the problem isn’t public confusion, it’s institutional insecurity.

 

For more:

Cellular Healing Bootcamp Tonight

https://pages.vitalplan.com/bootcamp/?  Go here for video & to sign up

 Free from Lyme and Chronic Illness

Kickoff event: Thursday Jan. 8

Bootcamp: Jan 13-Feb 2

The Cellular Healing Bootcamp includes 21 days of education and encouragement, featuring:

Who is this Bootcamp for?

Anyone living with complex chronic illness (whether or not you have a formal diagnosis), including: Chronic Lyme & co-infections, Fibromyalgia, ME/CFS, Mold toxicity, MCAS, Chronic pain or fatigue, Long COVID & Persistent post-infection symptoms. If you’ve struggled to improve with conventional approaches, this Bootcamp is an excellent place to begin.

Questions we get about our Bootcamp:

“The Bootcamp helped me “re-boot” my efforts and belief that healing is possible.  The information was informative and inspiring.  I’m so grateful!”  – Deb C. 2025 Bootcamp Attendee  

Short daily lessons
Approachable videos + simple action steps from Bill Rawls, MD and the Vital Plan Team

“Every day with the Vital Plan group is helpful!
Very supportive, informative, and encouraging!” – Shelley G.  

About Dr. Bill Rawls

Our Cellular Healing Bootcamp is a free, 21-day, expert-led community experience designed to support true healing by calming the nervous system, supporting detoxification, and restoring health at the cellular level.

Sign Up »

Dr. Bill Rawls
MEDICAL DIRECTOR
Vital Plan & RawlsMD

Beth Lambert
EXECUTIVE DIRECTOR
Documenting Hope

Matt & Rich
FOUNDERS 
Tick Boot Camp

Belinda Macri
HEALTH COACH
Vital Plan

Tim Yarborough
CUSTOMER SUCCESS
Vital Plan

• Chronic Lyme & co-infections

• Fibromyalgia

• ME/CFS

• Post-viral syndromes

• Mold toxicity

This bootcamp is virtual, free to join, and is ideal for anyone navigating complex or infection-associated chronic illness, including:

• MCAS, dysautonomia, chronic pain, and fatigue

• Long COVID

• Persistent, unexplained symptoms that haven’t responded to traditional approaches

Herbal support & lifestyle shifts

Our expertise in the therapeutic use of adaptogenic and antimicrobial herbs helps participants understand how herbal therapy, environment, diet, movement, and daily habits work together to shift the healing terrain.

When cellular stress accumulates, low-virulence microbes can become active again, triggering symptoms commonly seen in chronic Lyme and other complex chronic conditions. 

This bootcamp is grounded in the science-based framework developed by Dr. Bill Rawls and offers a holistic, time-tested path toward healing.

True recovery starts by removing the stressors that impair cellular function. The program is built around three essential pillars:

1. CALM
Regulate your nervous system and reduce cellular stress

2. DETOXIFY
Lighten your toxic load and support gut & immune balance

3. RESTORE
Build cellular resilience through herbs, diet, and lifestyle

Community accelerates healing

Doing this work in a supportive community helps reduce isolation, increase confidence, and sustain momentum.

Learn more about the Vital Plan Network.

Live expert events + replays
With guests including Beth Lambert, Tick Boot Camp, and the Vital Plan health coaches

Reflection time & check-ins
Daily prompts, shared insights, gentle accountability, and space for connection.

A dedicated bootcamp space
Inside the Vital Plan Network, accessible on desktop or our mobile app.

Downloadable
Guide
To help you keep focused on core concepts as you progress through the bootcamp.

Kick-off & celebration event
Meet the team, learn how the Bootcamp works, and close the experience with clarity and momentum.

Paulette Biancucci
HEALTH COACH
Vital Plan

Liza Blas
COMMUNITY MANAGER
Vital Plan Network

Where does the Bootcamp take place?

Entirely inside the Vital Plan Network—our private community platform where you can watch lessons, share reflections, and connect with others. Accessible via browser or our mobile app.

What is the Cellular Healing Bootcamp?

A free, 21-day community-based healing program designed to introduce you experientially to the core principles that support recovery from Lyme and other chronic illnesses: calming the nervous system, detoxifying the body, and restoring cellular resilience and freedom from reactivated microbes.

Do I need to attend live events?

Attending live is recommended but not required as much of the bootcamp will take place asynchronously. Replays for live events will be available, including for the Kickoff, expert webinars, and the final celebration.

What if I can’t keep up with daily lessons?

No problem! The content is intentionally short and paced with integration days. You can move at your own rhythm, catch up or skip if you need to.

Do I need any special supplements or tools?

No, just access to the Vital Plan Network via the web or our app.

Is this appropriate for beginners?

Absolutely. The Bootcamp is designed to meet you wherever you are in your recovery.

Can I join if I did last year’s Bootcamp?

Yes! This is our second annual Bootcamp and it includes new content, new lessons, and deeper community integration.

Hosted in the Vital Plan Network

The entire bootcamp takes place inside our private community platform—created by Dr. Rawls and purpose-built for people recovering from chronic illness.

In the Vital Plan Network you’ll find:

  • A dedicated bootcamp space
  • A supportive environment
  • Mentors and health coaches
  • Direct guidance from Dr. Rawls and the VP team
  • Courses, resources, and tools to continue your healing path

We recommend downloading the Vital Plan Network app for the best experience.

Emily Grimes
HEALTH COACH
Vital Plan

Hosted in
The Vital Plan Network

Kickoff Event:

Thursday Jan. 8th

Bootcamp:

Jan. 13th – Feb. 2nd

Cancer Journal Cyberattacked After Confirming Global mRNA ‘Vaccine’ Turbo Cancer Crisis

https://lionessofjudah.substack.com/p/breaking-major-cancer-journal-hit?

BREAKING: MAJOR Cancer Journal Hit With CYBERATTACK After Confirming Global mRNA “Vaccine” Turbo Cancer Crisis

“A Major Cancer Journal has just confirmed a global turbo cancer safety signal with the COVID-19 mRNA Injections, and they have faced a cyber attack as a result…”

Source: Nicolas Hulscher, MPH

Criminal DDoS attacks are blocking publication of the most comprehensive COVID-19 “vaccine” oncologic safety assessment ever conducted.

A Major Cancer Journal (Oncotarget) has just confirmed a global turbo cancer safety signal with the COVID-19 mRNA Injections.

And they have faced a cyber attack as a result, purportedly and possibly, from members associated with Pub Peer or what’s called Pub Smear, the Pub Smear mob, may be involved in illegal and criminal activities.

This has disrupted access to the study.

Due to this, the journal can not put this important paper into the public domain because they are currently under cyber intrusion.

The incident has been reported to the FBI and they are currently in contact with federal investigators to find out who is behind this criminal activity, preventing critical cancer data from being released to the public.  (See link for article)

_______________

Important quote:

For the first time, a major cancer journal has consolidated what many clinicians, pathologists, and researchers have already recognized and placed it permanently into the peer-reviewed scientific record. At this point, continued refusal by federal health agencies to acknowledge these signals represents criminal negligence.

Hence, the paper had to be ‘disappeared,’ a common tactic now.

Those responsible for cybercriminal interference will ultimately be held accountable — and regulators who ignored or suppressed post-vaccination cancer signals cannot escape responsibility for the human consequences. Every preventable post-vaccination cancer now rests squarely with regulatory authorities who ignored, dismissed, or suppressed clear safety warnings.

Source

It’s gettin’ hot in the kitchen!

The attacked paper only shows what experts have been screaming about for YEARS.  The gene therapy shots causing cancer is nothing new.

For more:

For Hope:

The Ethical Cost of Dismissing PTLDS

https://danielcameronmd.com/ptlds-ethical-challengesptlds-ethical-challenges/

The Ethical Cost of Dismissing PTLDS

1/3/26

The ethical challenges of post-treatment Lyme disease syndrome (PTLDS) often begin at the moment symptoms persist after treatment. Patients may do everything right—receive a timely diagnosis, complete recommended antibiotics, and follow medical advice—yet continue to worsen.

This is not simply a clinical dilemma. It is an ethical one.


Why This Matters Clinically

These ethical challenges are not theoretical. They shape diagnostic decisions, treatment options, insurance coverage, and whether patients remain engaged in care or are quietly discharged when recovery does not follow expected timelines.


The Ethical Challenges of PTLDS Begin at the First Dismissal

A month after a confirmed Lyme disease diagnosis, she completed the standard 21-day course of doxycycline. Her bull’s-eye rash had faded. But the fatigue didn’t lift. The joint pain spread. She began forgetting names, appointments, even how to get home on familiar roads.

When she returned to her primary doctor, she was told the infection was gone. “This sounds like stress,” one physician said. Another suggested early menopause. A third offered an SSRI.

None mentioned post-treatment Lyme disease syndrome (PTLDS). None discussed the possibility of persistent infection. And none explored co-infections.

She wasn’t just dismissed. She was excluded from her own care.

Patient experiences of delayed recognition and dismissal after Lyme treatment are explored further in She Was Told To Wait. Then Told It Was PTLDS.


When Patients Lose Autonomy in PTLDS Care

One of the most overlooked PTLDS ethical challenges is the erosion of patient autonomy. This patient was not given the information necessary to participate meaningfully in decisions about her care. Without acknowledgment of ongoing symptoms or discussion of uncertainty, informed consent became impossible.

She was told she was fine—when she wasn’t. That silence didn’t just delay treatment. It stripped her of agency.


Nonmaleficence: The Harm of Being Dismissed

The ethical principle of nonmaleficence—to do no harm—can be violated not only through action, but through omission.

Over the next six months, she deteriorated. Her work performance suffered. Her relationships strained. She began to question her own perceptions and sanity.

Her harm did not come from over-treatment. It came from disbelief, inaction, and the refusal to consider alternatives when standard explanations failed.

Dismissing the possibility of persistent tick-borne infection does not protect patients. It compounds their suffering.

Diagnostic uncertainty and downstream harm caused by delayed or incomplete evaluation are examined in Problems with PTLDS Diagnosis.


Beneficence: Patients Deserve More Than Protocols

When she eventually came to my office, she brought a binder of labs, symptom charts, and denial letters. What she wanted was not reassurance—it was to be evaluated as a whole person.

We reviewed her history carefully, including tick exposure, prior antibiotic response, neurocognitive and autonomic symptoms, and co-infection risk such as Babesia and Bartonella.

Further evaluation revealed equivocal Babesia titers and autonomic testing consistent with POTS. Clinically, her presentation was consistent with persistent Lyme disease.

Her treatment plan addressed multiple dimensions, including antimicrobial therapy, antiparasitic treatment, POTS management, and cognitive and nutritional support.

Gradually, her symptoms improved. But nearly a year had passed before anyone looked beyond the protocol.

Beneficence requires doing what is best for the patient—not only what guidelines allow.

Clinical decision-making around individualized care after standard therapy is discussed in Intravenous Antibiotics and Post-Treatment Lyme Disease Syndrome (PTLDS).


Justice: Who Gets Believed, and Who Gets Left Behind?

The justice-related ethical challenges of PTLDS are “ethical consequences”.

This patient was denied insurance coverage for extended care, access to knowledgeable specialists, and disability benefits despite functional impairment. She was treated as a liability rather than a person in distress.

The skepticism surrounding PTLDS has created a two-tiered system: those who are believed and treated, and those who are dismissed.

Justice demands better.

The broader implications of contested terminology and access to care are addressed in Chronic Lyme vs PTLDS: The Debate.


Fidelity: The Ethical Duty to Stay With the Patient

Fidelity means remaining loyal to patients, even when answers are incomplete. For individuals with PTLDS, this often means acknowledging uncertainty, continuing evaluation, and refusing to abandon care simply because tests are normal.

This patient did not need false certainty. She needed someone to say, “I believe you. Let’s keep looking.”

That commitment alone can alter the course of chronic illness.


Disclosure and Ethical Uncertainty in PTLDS

An additional ethical concern arises when patients are not informed that the underlying cause of PTLDS remains debated. Immune dysregulation, neuroinflammation, autonomic dysfunction, and central sensitization are commonly discussed. Some clinicians also raise the possibility that persistent infection may contribute to symptoms in a subset of patients.

When this debate is omitted entirely, patients are denied a full understanding of their condition and the range of clinical perspectives that exist.

Patients deserve transparency. Silence is not ethical care.

A broader clinical overview of definitions, proposed mechanisms, and current understanding is discussed in What Is Post-Treatment Lyme Disease Syndrome (PTLDS)?

Ethical responsibility in Lyme disease care, including the role of clinical judgment when evidence is incomplete, is discussed in Ethical Lyme Disease Care: When Clinical Judgment Matters.


Conclusion: PTLDS Ethical Challenges Demand More Than Silence

This case is not rare. It reflects a growing population of patients harmed not only by illness, but by institutional neglect.

The ethical challenges of PTLDS require more than academic debate. They require action.

We must support autonomy through honest disclosure. We must avoid harm caused by disbelief, individualize care beyond rigid protocols, pursue justice in access to treatment, and remain with patients when answers are incomplete.

PTLDS is not a myth. Ignoring it is.


Clinician Mini-FAQ

Is discussing persistent infection ethical in PTLDS?
Yes. Ethical care requires disclosure of uncertainty and ongoing debate, even when mechanisms are not fully resolved.

Does acknowledging PTLDS mean abandoning evidence-based medicine?
No. It means applying evidence with humility, clinical judgment, and continued responsibility to the patient.


Selected References

Clinical Infectious Diseases Aucott JN, Rebman AW, Crowder LA, Kortte KB. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning 2013;57(2):333–340. Pubmed

Neurobiology of Disease Fallon BA, Levin ES, Schweitzer PJ, Hardesty D. Inflammation and central nervous system Lyme disease. 2010 Mar;37(3):534–541.. Pubmed

Infectious Disease Clinics of North America Marques A. Chronic Lyme disease: a review. Infect Dis Clin North Am. 2008;22(2):341–360. Pubmed

______________

**Comment**

This needed to be written.

It also exemplifies why RFK’s proclamation that the ‘gaslighting of Lyme patients is over,’ is vastly oversimplified.

The entire Lyme/MSIDS paradigm needs a ‘do over.’

Every single thing about it’s history is shrouded in bias and faulty or incomplete science.